CN102680703A - 一种快速定量检测肌红蛋白的免疫荧光试纸条组件及其制成的检测卡组件和制备方法 - Google Patents
一种快速定量检测肌红蛋白的免疫荧光试纸条组件及其制成的检测卡组件和制备方法 Download PDFInfo
- Publication number
- CN102680703A CN102680703A CN2012101335709A CN201210133570A CN102680703A CN 102680703 A CN102680703 A CN 102680703A CN 2012101335709 A CN2012101335709 A CN 2012101335709A CN 201210133570 A CN201210133570 A CN 201210133570A CN 102680703 A CN102680703 A CN 102680703A
- Authority
- CN
- China
- Prior art keywords
- myoglobins
- test strips
- antibody
- detection
- immunofluorescence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 127
- 238000010166 immunofluorescence Methods 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 102000036675 Myoglobin Human genes 0.000 title abstract description 9
- 108010062374 Myoglobin Proteins 0.000 title abstract description 9
- 239000012528 membrane Substances 0.000 claims abstract description 32
- 241000283973 Oryctolagus cuniculus Species 0.000 claims abstract description 23
- 238000001514 detection method Methods 0.000 claims description 73
- NPRDEIDCAUHOJU-UHFFFAOYSA-N [Pt].N1C(C=C2N=C(C=C3NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 Chemical class [Pt].N1C(C=C2N=C(C=C3NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 NPRDEIDCAUHOJU-UHFFFAOYSA-N 0.000 claims description 43
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 30
- 230000000274 adsorptive effect Effects 0.000 claims description 26
- 238000013016 damping Methods 0.000 claims description 25
- 239000012530 fluid Substances 0.000 claims description 25
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 22
- 229940098773 bovine serum albumin Drugs 0.000 claims description 22
- 239000008363 phosphate buffer Substances 0.000 claims description 21
- 238000004806 packaging method and process Methods 0.000 claims description 17
- 238000011002 quantification Methods 0.000 claims description 16
- 239000000020 Nitrocellulose Substances 0.000 claims description 14
- 229920001220 nitrocellulos Polymers 0.000 claims description 14
- 239000004033 plastic Substances 0.000 claims description 14
- 229920003023 plastic Polymers 0.000 claims description 14
- 239000004094 surface-active agent Substances 0.000 claims description 12
- 238000010790 dilution Methods 0.000 claims description 11
- 239000012895 dilution Substances 0.000 claims description 11
- 238000007789 sealing Methods 0.000 claims description 11
- 239000007921 spray Substances 0.000 claims description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 10
- 239000003153 chemical reaction reagent Substances 0.000 claims description 10
- 239000004793 Polystyrene Substances 0.000 claims description 9
- 238000012856 packing Methods 0.000 claims description 9
- 229920002223 polystyrene Polymers 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 8
- 238000007639 printing Methods 0.000 claims description 8
- 238000001291 vacuum drying Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 229920000151 polyglycol Polymers 0.000 claims description 7
- 239000010695 polyglycol Substances 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 7
- 239000005030 aluminium foil Substances 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 239000003365 glass fiber Substances 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 239000006166 lysate Substances 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 3
- WFCSWCVEJLETKA-UHFFFAOYSA-N 2-piperazin-1-ylethanol Chemical compound OCCN1CCNCC1 WFCSWCVEJLETKA-UHFFFAOYSA-N 0.000 claims description 3
- 229920000297 Rayon Polymers 0.000 claims description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 239000002390 adhesive tape Substances 0.000 claims description 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 3
- 230000005284 excitation Effects 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 206010013786 Dry skin Diseases 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 7
- 238000004458 analytical method Methods 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 2
- 239000008280 blood Substances 0.000 abstract description 2
- 210000002966 serum Anatomy 0.000 abstract description 2
- 230000002745 absorbent Effects 0.000 abstract 1
- 239000002250 absorbent Substances 0.000 abstract 1
- 210000002381 plasma Anatomy 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 6
- 125000000539 amino acid group Chemical group 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 206010061216 Infarction Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 230000007574 infarction Effects 0.000 description 4
- 210000004165 myocardium Anatomy 0.000 description 4
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 3
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 3
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000003759 clinical diagnosis Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- -1 iron porphyrin compound Chemical class 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 210000002027 skeletal muscle Anatomy 0.000 description 3
- 208000005189 Embolism Diseases 0.000 description 2
- 208000001435 Thromboembolism Diseases 0.000 description 2
- 102100026893 Troponin T, cardiac muscle Human genes 0.000 description 2
- 101710165323 Troponin T, cardiac muscle Proteins 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000010219 correlation analysis Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000003317 immunochromatography Methods 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- JQRLYSGCPHSLJI-UHFFFAOYSA-N [Fe].N1C(C=C2N=C(C=C3NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 Chemical compound [Fe].N1C(C=C2N=C(C=C3NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 JQRLYSGCPHSLJI-UHFFFAOYSA-N 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 238000011095 buffer preparation Methods 0.000 description 1
- 238000002038 chemiluminescence detection Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000002558 medical inspection Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 150000004032 porphyrins Chemical group 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003233 pyrroles Chemical class 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical group O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210133570.9A CN102680703B (zh) | 2012-04-28 | 2012-04-28 | 一种快速定量检测肌红蛋白的免疫荧光试纸条组件及其制成的检测卡组件和制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210133570.9A CN102680703B (zh) | 2012-04-28 | 2012-04-28 | 一种快速定量检测肌红蛋白的免疫荧光试纸条组件及其制成的检测卡组件和制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102680703A true CN102680703A (zh) | 2012-09-19 |
CN102680703B CN102680703B (zh) | 2014-12-17 |
Family
ID=46812946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210133570.9A Active CN102680703B (zh) | 2012-04-28 | 2012-04-28 | 一种快速定量检测肌红蛋白的免疫荧光试纸条组件及其制成的检测卡组件和制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102680703B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018120855A1 (zh) * | 2016-12-28 | 2018-07-05 | 广州瑞博奥生物科技有限公司 | 检测myo的时间分辨荧光免疫层析试纸条、试剂盒及其制备方法 |
CN109142719A (zh) * | 2018-07-10 | 2019-01-04 | 广州佰芮慷生物科技有限公司 | 一种检测方法 |
CN109725151A (zh) * | 2018-12-28 | 2019-05-07 | 江苏众红生物工程创药研究院有限公司 | 人肌红蛋白检测试纸卡及其临床应用 |
CN109725154A (zh) * | 2018-10-08 | 2019-05-07 | 杭州康知生物科技有限公司 | 一种IgG4荧光免疫层析测定试剂盒及测定方法 |
CN112305228A (zh) * | 2019-07-31 | 2021-02-02 | 上海奥普生物医药股份有限公司 | 一种肌红蛋白直接化学发光检测试剂盒、制备方法及用途 |
CN112698036A (zh) * | 2020-12-22 | 2021-04-23 | 上海理工大学 | 细菌单克隆抗体交叉反应快速测定免疫试纸条及测定方法 |
CN113929777A (zh) * | 2020-07-13 | 2022-01-14 | 东莞市朋志生物科技有限公司 | 抗肌红蛋白的抗体、检测肌红蛋白的试剂盒和方法 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1092424A (zh) * | 1992-10-30 | 1994-09-21 | 夸德拉逻辑技术股份有限公司 | 对特定波长光敏的卟菲花青和扩增的类卟啉化合物及其制备和使用方法 |
EP0978568A2 (en) * | 1998-08-03 | 2000-02-09 | Bayer Corporation | Method for the prevention of hemoglobin interference in reagent systems for measuring peroxidase activity |
US20050112703A1 (en) * | 2003-11-21 | 2005-05-26 | Kimberly-Clark Worldwide, Inc. | Membrane-based lateral flow assay devices that utilize phosphorescent detection |
US20090111171A1 (en) * | 2003-02-13 | 2009-04-30 | Inverness Medical Switzerland Gmbh | Lateral flow immunoassay controls |
CN101710066A (zh) * | 2009-12-23 | 2010-05-19 | 重庆大学 | 检测有机磷农药残留量的方法及液态卟啉光学检测装置 |
CN101776601A (zh) * | 2010-01-25 | 2010-07-14 | 泸州老窖集团有限责任公司 | 一种快速检测农药残留的方法 |
CN102023211A (zh) * | 2010-11-19 | 2011-04-20 | 广州万孚生物技术有限公司 | 一种全程定量检测c反应蛋白的免疫层析试纸条及其制备方法 |
CN102087293A (zh) * | 2010-12-31 | 2011-06-08 | 广州万孚生物技术有限公司 | 一种全程定量检测肌钙蛋白i的免疫层析试纸条及其制备方法 |
CN102183647A (zh) * | 2011-01-24 | 2011-09-14 | 杭州师范大学 | 一种乙型肝炎病毒表面抗原的检测试剂及检测方法 |
CN202049158U (zh) * | 2010-12-09 | 2011-11-23 | 苏州生物医学工程技术研究所 | 一种免疫荧光试纸条 |
CN102393463A (zh) * | 2011-10-21 | 2012-03-28 | 广州万孚生物技术有限公司 | 荧光定量检测沙丁胺醇的试剂盒和荧光标记液的制备方法 |
-
2012
- 2012-04-28 CN CN201210133570.9A patent/CN102680703B/zh active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1092424A (zh) * | 1992-10-30 | 1994-09-21 | 夸德拉逻辑技术股份有限公司 | 对特定波长光敏的卟菲花青和扩增的类卟啉化合物及其制备和使用方法 |
EP0978568A2 (en) * | 1998-08-03 | 2000-02-09 | Bayer Corporation | Method for the prevention of hemoglobin interference in reagent systems for measuring peroxidase activity |
US20090111171A1 (en) * | 2003-02-13 | 2009-04-30 | Inverness Medical Switzerland Gmbh | Lateral flow immunoassay controls |
US20050112703A1 (en) * | 2003-11-21 | 2005-05-26 | Kimberly-Clark Worldwide, Inc. | Membrane-based lateral flow assay devices that utilize phosphorescent detection |
CN101710066A (zh) * | 2009-12-23 | 2010-05-19 | 重庆大学 | 检测有机磷农药残留量的方法及液态卟啉光学检测装置 |
CN101776601A (zh) * | 2010-01-25 | 2010-07-14 | 泸州老窖集团有限责任公司 | 一种快速检测农药残留的方法 |
CN102023211A (zh) * | 2010-11-19 | 2011-04-20 | 广州万孚生物技术有限公司 | 一种全程定量检测c反应蛋白的免疫层析试纸条及其制备方法 |
CN202049158U (zh) * | 2010-12-09 | 2011-11-23 | 苏州生物医学工程技术研究所 | 一种免疫荧光试纸条 |
CN102087293A (zh) * | 2010-12-31 | 2011-06-08 | 广州万孚生物技术有限公司 | 一种全程定量检测肌钙蛋白i的免疫层析试纸条及其制备方法 |
CN102183647A (zh) * | 2011-01-24 | 2011-09-14 | 杭州师范大学 | 一种乙型肝炎病毒表面抗原的检测试剂及检测方法 |
CN102393463A (zh) * | 2011-10-21 | 2012-03-28 | 广州万孚生物技术有限公司 | 荧光定量检测沙丁胺醇的试剂盒和荧光标记液的制备方法 |
Non-Patent Citations (1)
Title |
---|
李改茹等: "金属钯/铂卟啉室温磷光探针在生物医学领域的应用研究", 《分析化学评述与进展》 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018120855A1 (zh) * | 2016-12-28 | 2018-07-05 | 广州瑞博奥生物科技有限公司 | 检测myo的时间分辨荧光免疫层析试纸条、试剂盒及其制备方法 |
CN109142719A (zh) * | 2018-07-10 | 2019-01-04 | 广州佰芮慷生物科技有限公司 | 一种检测方法 |
CN109725154A (zh) * | 2018-10-08 | 2019-05-07 | 杭州康知生物科技有限公司 | 一种IgG4荧光免疫层析测定试剂盒及测定方法 |
CN109725151A (zh) * | 2018-12-28 | 2019-05-07 | 江苏众红生物工程创药研究院有限公司 | 人肌红蛋白检测试纸卡及其临床应用 |
CN109725151B (zh) * | 2018-12-28 | 2021-08-27 | 江苏众红生物工程创药研究院有限公司 | 人肌红蛋白检测试纸卡及其临床应用 |
CN112305228A (zh) * | 2019-07-31 | 2021-02-02 | 上海奥普生物医药股份有限公司 | 一种肌红蛋白直接化学发光检测试剂盒、制备方法及用途 |
CN113929777A (zh) * | 2020-07-13 | 2022-01-14 | 东莞市朋志生物科技有限公司 | 抗肌红蛋白的抗体、检测肌红蛋白的试剂盒和方法 |
CN112698036A (zh) * | 2020-12-22 | 2021-04-23 | 上海理工大学 | 细菌单克隆抗体交叉反应快速测定免疫试纸条及测定方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102680703B (zh) | 2014-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102680703B (zh) | 一种快速定量检测肌红蛋白的免疫荧光试纸条组件及其制成的检测卡组件和制备方法 | |
CN108254562B (zh) | 检测myo的时间分辨荧光免疫层析试纸条、试剂盒及其制备方法 | |
CN102662055A (zh) | 一种快速定量检测肌钙蛋白i的免疫荧光试纸条组件、及其制成的检测卡组件和制备方法 | |
CN102662065B (zh) | 一种快速定量检测多种蛋白的免疫荧光试纸条组件及其制成的检测卡组件和制备方法 | |
CN108254563B (zh) | 检测cTnI的时间分辨荧光免疫层析试纸条、试剂盒及其制备方法 | |
CN102680702B (zh) | 一种快速定量检测c-反应蛋白的免疫荧光试纸条组件、及其制成的检测卡组件和制备方法 | |
CN108254550B (zh) | 检测ck-mb的时间分辨荧光免疫层析试纸条、试剂盒及其制备方法 | |
CN102539785B (zh) | 一种全程定量检测c-反应蛋白的荧光免疫层析方法及其试剂盒 | |
CN105652008A (zh) | 人Lp-PLA2生物素-链霉亲和素荧光免疫层析检测卡及其制备方法 | |
CN102207507A (zh) | 心肌肌钙蛋白半定量检测试纸及制备方法 | |
CN102680704B (zh) | 一种快速定量检测微量白蛋白的免疫荧光试纸条组件及其制成的检测卡组件和制备方法 | |
CN101949944A (zh) | 三碘甲状腺原氨酸定量检测试剂盒及其制备方法 | |
CN102707056A (zh) | 快速定量检测心肌肌酸激酶同工酶的免疫荧光试纸条组件及其制成的检测卡组件和制备方法 | |
CN101377505A (zh) | 脱γ羧基凝血酶原微孔板化学发光免疫分析测定试剂盒及其制备方法 | |
CN101566631A (zh) | 一种联合检测hiv-1+2抗体和p24抗原的磁性免疫层析试纸条及其制备方法 | |
CN101566634A (zh) | 肌钙蛋白ⅰ血清快速检测试剂盒(胶体金法) | |
CN107966561A (zh) | 一种检测hiv抗体的试纸条和试剂盒 | |
CN205484371U (zh) | 一种肿瘤标志物检测试剂盒 | |
WO2003083479A1 (fr) | Procede et dispositif de traitement du sang, procede et dispositif de mesure des hemoglobines | |
CN102692508B (zh) | 一种快速定量检测肌钙蛋白t的免疫荧光试纸条组件及其制成的检测卡组件和制备方法 | |
CN108226468A (zh) | 一种检测NT-proBNP的试纸条及其制备方法与应用 | |
CN107490693A (zh) | 一种定量检测心肌肌钙蛋白i和心型脂肪酸结合蛋白的荧光免疫层析方法 | |
CN106885899A (zh) | 定量检测Lp‑PLA2的时间分辨荧光免疫分析试纸条及其制备方法 | |
CN104049088A (zh) | 一种血浆hsp70抗体化学发光定量检测试剂盒 | |
CN103995116B (zh) | 用于特异性头孢菌素类抗生素过敏原IgE筛查的试纸条及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Immunofluorescence test strip component for quickly and quantitatively testing myoglobin, test card component using immunofluorescence test strip component, and preparation method for immunofluorescence test strip component Effective date of registration: 20180202 Granted publication date: 20141217 Pledgee: Bank of Guangzhou branch of the Bank of Guangzhou Science City Branch Pledgor: GUANGZHOU HONGQI OPTICAL INSTRUMENT TECHNOLOGY Co.,Ltd. Registration number: 2018440000032 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190225 Granted publication date: 20141217 Pledgee: Bank of Guangzhou branch of the Bank of Guangzhou Science City Branch Pledgor: GUANGZHOU HONGQI OPTICAL INSTRUMENT TECHNOLOGY Co.,Ltd. Registration number: 2018440000032 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Immunofluorescence test strip component for quickly and quantitatively testing myoglobin, test card component using immunofluorescence test strip component, and preparation method for immunofluorescence test strip component Effective date of registration: 20190304 Granted publication date: 20141217 Pledgee: Guangzhou Branch of Guangzhou Bank Co.,Ltd. Pledgor: GUANGZHOU HONGQI OPTICAL INSTRUMENT TECHNOLOGY Co.,Ltd. Registration number: 2019440000084 |
|
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20190729 Granted publication date: 20141217 |
|
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20220729 Granted publication date: 20141217 |
|
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20220729 Granted publication date: 20141217 |